SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?


To: StockDoc who wrote (3984)4/3/1998 1:21:00 PM
From: sam  Respond to of 6136
 
10 billion a year would be nice for a biotech/pharm with a market cap under 1 billion. I guess the street doesn't yet believe the drug has any potential market. Either does Tiger -- a major short in AGPH. I'd love for them to be wrong. I guess we'll just have to wait, though.



To: StockDoc who wrote (3984)4/3/1998 1:28:00 PM
From: bill small  Respond to of 6136
 
sounds like AG3340 is most promising;where is it the the trial process?

thanks for your insights.....Bill